Pulmonary Hypertension: A Cancerous Proliferative Vascular Disorder?

All credit to Prof. Serge Adnot, Professor of Physiology at INSERM, Creteil, France

Part 3

Additional key-words: malignancy,clinical trials,serotonin

About the author

France

France

Authors: Fernandes L, Silva FJG, Alexandre R Source: Micromachines (Basel)

Authors: Morgan KA, Tang T, Zeimpekis I, Ravagli A, Craig C, Yao J, Feng Z, Yarmolich D, Barker C, Assender H, Hewak DW Source: Sci Rep

Authors: Moore AR, Huang G, Wolf S, Walsh PJ, Fakhraai Z, Riggleman RA Source: Proc Natl Acad Sci U S A

Authors: Wu Q, Gao W, Zhou J, He G, Ye J, Fang F, Luo J, Wang M, Xu H, Wang W Source: Microvasc Res

Authors: Suker M, Tovar Doncel MS, Pinto Lima AA, Ince C, van Eijck CHJ Source: Clin Hemorheol Microcirc

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI